The DOI matches its Crossref record.
Cytokine production induced by Mycobacterium tuberculosis lipoarabinomannan. Relationship to chemical structure
Abstract
Lipoarabinomannan (LAM), a major cell wall component of Mycobacterium tuberculosis, exhibits a wide spectrum of immunoregulatory effects. To identify cytokines produced by human PBMC in response to LAM, we used PCR amplification to detect cytokine mRNA. LAM-induced transcription of mRNA for cytokines characteristically produced by macrophages, including TNF, granulocyte-macrophage-CSF, IL-1 alpha, IL-1 beta, IL-6, IL-8, and IL-10. In contrast, LAM did not induce transcription of mRNA for cytokines produced predominantly by lymphocytes, such as lymphotoxin, IFN-gamma, IL-2, IL-3, or IL-4. Measurement of concentrations of TNF, granulocyte-macrophage-CSF, IL-6, IL-10, IFN-gamma, IL-2, and IL-4 in cell culture supernatants indicated that cytokine release correlated with mRNA patterns. Lipomannan (LM) and phosphatidylinositol mannosides (PIM) are simpler versions of LAM. LM lacks arabinan, whereas PIM lacks both arabinan and most mannan residues. LAM, LM, and PIM induced transcription of cytokine mRNA, elicited cytokine production, and suppressed Ag-induced T cell proliferation, indicating that most of the biologic activity of LAM was associated with the phosphatidylinositol end of the molecule. In support of this conclusion, deacylation of LAM abrogated its capacity to induce cytokine production and suppress Ag-induced proliferation. The production of macrophage-derived cytokines induced by LAM may mediate clinical manifestations of tuberculosis such as fever, weight loss, and tissue necrosis, as well as immunoregulatory effects such as inhibition of Ag-induced proliferation and hyperglobulinemia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
lnterleukin-8 and Related Chemotactic Cytokines—CXC and CC Chemokines
Baggiolini, M., Dewald, B., & Moser, B. (1993) · Advances in Immunology · doi:10.1016/s0065-2776(08)60509-x · Cited by 1,671
The Continuing Challenges of Leprosy
Scollard, D. M., Adams, L. B., Gillis, T. P., Krahenbuhl, J. L., Truman, R. W., & Williams, D. L. (2006) · Clinical Microbiology Reviews · doi:10.1128/cmr.19.2.338-381.2006 · Cited by 928
The Envelope Layers of Mycobacteria with Reference to their Pathogenicity
Daffé, M., & Draper, P. (1997) · Advances in Microbial Physiology · doi:10.1016/s0065-2911(08)60016-8 · Cited by 730
Type 1 and type 2 cytokine dysregulation in human infectious, neoplastic, and inflammatory diseases
Lucey, D. R., Clerici, M., & Shearer, G. M. (1996) · Clinical Microbiology Reviews · doi:10.1128/cmr.9.4.532 · Cited by 666
Modes of action of Freund's adjuvants in experimental models of autoimmune diseases
Billiau, A., & Matthys, P. (2001) · Journal of Leukocyte Biology · doi:10.1189/jlb.70.6.849 · Cited by 617
Cross-regulatory roles of interleukin (IL)-12 and IL-10 in atherosclerosis.
Uyemura, K., Demer, L. L., Castle, S. C., Jullien, D., Berliner, J. A., Gately, M. K., Warrier, R. R., Pham, N., Fogelman, A. M., & Modlin, R. L. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118650 · Cited by 427
Self-citationBriken, V., Porcelli, S. A., Besra, G. S., & Kremer, L. (2004) · Molecular Microbiology · doi:10.1111/j.1365-2958.2004.04183.x · Cited by 425
Nigou, J., Zelle-Rieser, C., Gilleron, M., Thurnher, M., & Puzo, G. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.12.7477 · Cited by 423
Henderson, B., Poole, S., & Wilson, M. (1996) · Microbiological Reviews · doi:10.1128/mmbr.60.2.316-341.1996 · Cited by 419
Tsuji, S., Matsumoto, M., Takeuchi, O., Akira, S., Azuma, I., Hayashi, A., Toyoshima, K., & Seya, T. (2000) · Infection and Immunity · doi:10.1128/iai.68.12.6883-6890.2000 · Cited by 409
Cytokine production at the site of disease in human tuberculosis
Barnes, P. F., Lu, S., Abrams, J. S., Wang, E., Yamamura, M., & Modlin, R. L. (1993) · Infection and Immunity · doi:10.1128/iai.61.8.3482-3489.1993 · Cited by 371
Self-citationTrafficking and Release of Mycobacterial Lipids from Infected Macrophages
Beatty, W. L., Rhoades, E. R., Ullrich, H., Chatterjee, D., Heuser, J. E., & Russell, D. G. (2000) · Traffic · doi:10.1034/j.1600-0854.2000.010306.x · Cited by 363
Self-citationEffects of cytokines on mycobacterial phagosome maturation
Via, L. E., Fratti, R. A., McFalone, M., Pagán-Ramos, E., Deretic, D., & Deretic1, V. (1998) · Journal of Cell Science · doi:10.1242/jcs.111.7.897 · Cited by 356
Chatterjee, D., & Khoo, K.-H. (1998) · Glycobiology · doi:10.1093/glycob/8.2.113 · Cited by 351
Self-citationMcGuirk, P., & Mills, K. H. G. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02288-3 · Cited by 350
To respond or not to respond: T cells in allergic asthma
Herrick, C. A., & Bottomly, K. (2003) · Nature Reviews Immunology · doi:10.1038/nri1084 · Cited by 333
Takeuchi, O., Takeda, K., Hoshino, K., Adachi, O., Ogawa, T., & Akira, S. (2000) · International Immunology · doi:10.1093/intimm/12.1.113 · Cited by 326
Hijacking and exploitation of IL-10 by intracellular pathogens
Redpath, S., Ghazal, P., & Gascoigne, N. R. J. (2001) · Trends in Microbiology · doi:10.1016/s0966-842x(00)01919-3 · Cited by 317
Manca, C., Tsenova, L., Barry, C. E., Bergtold, A., Freeman, S., Haslett, P. A. J., Musser, J. M., Freedman, V. H., & Kaplan, G. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.11.6740 · Cited by 306
Immunopathology of tuberculosis: roles of macrophages and monocytes
Fenton, M. J., & Vermeulen, M. W. (1996) · Infection and Immunity · doi:10.1128/iai.64.3.683-690.1996 · Cited by 306
Toll-like receptor pathways in the immune responses to mycobacteria
Quesniaux, V., Fremond, C., Jacobs, M., Parida, S., Nicolle, D., Yeremeev, V., Bihl, F., Erard, F., Botha, T., Drennan, M., et al. (2004) · Microbes and Infection · doi:10.1016/j.micinf.2004.04.016 · Cited by 281
Lipoarabinomannans: from structure to biosynthesis
Nigou, J. (2003) · Biochimie · doi:10.1016/s0300-9084(03)00048-8 · Cited by 277
Hirsch, C. S., Toossi, Z., Othieno, C., Johnson, J. L., Schwander, S. K., Robertson, S., Wallis, R. S., Edmonds, K., Okwera, A., Mugerwa, R., et al. (1999) · The Journal of Infectious Diseases · doi:10.1086/315114 · Cited by 275
Quesniaux, V. J., Nicolle, D. M., Torres, D., Kremer, L., Guérardel, Y., Nigou, J., Puzo, G., Erard, F., & Ryffel, B. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.7.4425 · Cited by 259
Inflammatory cytokines overcome age-related defects in CD4 T cell responses in vivo
Haynes, L., Eaton, S. M., Burns, E. M., Rincon, M., & Swain, S. L. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.9.5194 · Cited by 162
Interleukin‐10, Polymorphism in SLC11A1(formerly NRAMP1), and Susceptibility to Tuberculosis
Awomoyi, A. A., Marchant, A., Howson, J. M. M., McAdam, K. P. W. J., Blackwell, J. M., & Newport, M. J. (2002) · The Journal of Infectious Diseases · doi:10.1086/345920 · Cited by 153
Reconsidering Adjuvant Immunotherapy for Tuberculosis
Wallis, R. S. (2005) · Clinical Infectious Diseases · doi:10.1086/430914 · Cited by 121
Kurtz, S., McKinnon, K. P., Runge, M. S., Ting, J. P.-Y., & Braunstein, M. (2006) · Infection and Immunity · doi:10.1128/iai.01022-06 · Cited by 114
CD4 + T Cells: Guardians of the Phagosome
Tubo, N. J., & Jenkins, M. K. (2014) · Clinical Microbiology Reviews · doi:10.1128/cmr.00097-13 · Cited by 105
Metadata
- Authors
- Barnes, P. F., Chatterjee, D., Abrams, J. S., Lu, S., Wang, E., Yamamura, M., Brennan, P. J., & Modlin, R. L.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 1992-07
- Volume
- 149
- Issue
- 2
- Pages
- 541-547
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1560324107
- Cited by
- 294
- References
- 0
- FWCI
- 15.13
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.